Systemic Lupus Erythematosus (SLE): A review on the prevalence, clinical manifestation, and disease assessment
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease with a varying clinical phenotype. This disease occurs when the body’s tissues are attacked by its own immune system. The aetiology of SLE is not fully understood, but both genetic predisposition and ecological triggers are thought to be involved in the disease manifestation. The study on the prevalence of SLE allows us to identify potential risk factors associated with the disease for the disease and allows proper management and treatment in response to overall disease burden. Hence, this review aims to discuss the prevalence, mortality, clinical manifestation and disease assessment of SLE.
Copyright (c) 2020 Malarvili Selvaraja, Maha Abdullah, Anim Md Shah, Masita Arip, Syafinaz Amin Nordin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Author(s) shall retain the copyright of their work and grant the Journal/Publisher right for the first publication with the work simultaneously licensed under:
Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows for the copying, distribution and transmission of the work, provided the correct attribution of the original creator is stated. Adaptation and remixing are also permitted.
This broad license intends to facilitate free access to, as well as the unrestricted reuse of, original works of all types for non-commercial purposes.
The author(s) permits HH Publisher to publish this article that has not been submitted elsewhere.